Subcutaneous undifferentiated pleomorphic sarcoma is more aggressive than pleomorphic dermal sarcoma: Prognosis from a Danish nationwide registry-based cohort
Our findings indicate that patients with scUPS have a significantly worse prognosis than patients with PDS, with a higher overall risk of metastasis and a prolonged metastatic risk. This suggests a more extended follow-up program focusing on the detection of distant metastasis for patients with scUPS, whereas the follow-up of patients with PDS can be limited to clinical controls.
Authors
- Mathilde N. Hemmingsen (ORCID: https://orcid.org/0000-0002-8439-6537)
- Thomas Mentzel (ORCID: https://orcid.org/0000-0002-1227-2578)
- Mathias Ørholt (ORCID: https://orcid.org/0000-0002-8815-8392)
- Anne Lene Wagenblast
- David Hebbelstrup Jensen (ORCID: https://orcid.org/0000-0002-8004-0752)
- Kiya Abebe
- Søren Daugaard
- Mikkel Herly (ORCID: https://orcid.org/0000-0002-5866-1173)
- Michael Mørk Petersen (ORCID: https://orcid.org/0000-0002-2324-6420)
- Peter Vester‐Glowinski
- Tim K. Weltz (ORCID: https://orcid.org/0000-0003-1432-3479)
- Anand C. Loya
- Grethe Schmidt (ORCID: https://orcid.org/0009-0000-1633-4003)
- Ida Wulff
Institutions
- Copenhagen University Hospital (DK)
- Rigshospitalet (DK)
- Dermatopathologie Friedrichshafen (DE)
Publication Details
- Journal
- European Journal of Surgical Oncology
- Published
- 2025-03-06
- DOI
- https://doi.org/10.1016/j.ejso.2025.109747
- Citations
- 1
- Primary Topic
- Sarcoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.52
Funders
- Rigshospitalet
- Novo Nordisk Fonden